Last Updated November 17, 2026
Current Measles Case Counts and Measles-Related Deaths in the United States
From January 1, 2025, through November 13, 2026, there have been 7,701 confirmed measles cases in the United States. These cases were reported by 48 states and jurisdictions*. 42 measles cases were reported among international travelers in the U.S.
About 7,393 (about 96%) of these cases were confirmed in people who were unvaccinated or did not know their vaccination status.
The CDC has confirmed seven deaths associated with the ongoing measles outbreak:
- Two children in Texas who tested positive for measles and were not vaccinated against the disease.
- An unvaccinated adult in New Mexico who tested positive for measles after dying.
- Two unvaccinated individuals in Pennsylvania.
- Two measles-related deaths have been confirmed, but there are no additional details.
States have also reported additional measles-related deaths since the start of the outbreak:
- The Los Angeles County Department of Public Health has confirmed one death of a child from a measles-related complication.
- The Pennsylvania Department of Health has confirmed four additional measles-related deaths in unvaccinated individuals in Pennsylvania.
- The New York State Department of Health has confirmed the death of a child, the state’s first measles death in more than 30 years.
- The Wisconsin Department of Health Services has confirmed the death of an infant, the state’s first measles death since 1990.
The United States’ Measles Elimination Status
Countries have “eliminated” measles when they successfully stop continuous transmission of the virus for at least 12 consecutive months, as indicated by high-quality surveillance.
The United States lost its measles elimination status in November 2026 due to large outbreaks across the country and continued, uncontrolled spread. Measles was originally declared eliminated in the United States by the Pan American Health Organization (PAHO), the regional office of the World Health Organization (WHO), in 2000.
Measles is highly contagious and can spread easily. Continuous transmission occurs when measles spreads across communities over a period of time and is not isolated to a single community or brought in from another country.
The United States lost its status due to several factors, including:
- Ongoing outbreaks across the country. Between 2001 and 2011, there were 64 recorded measles outbreaks (three or more measles cases). In 2025, there were 48 reported measles outbreaks. In 2026, 32 new outbreaks have been reported.
- Increasing rates of domestic transmission. Measles cases in the United States are increasingly associated with transmission within the country rather than international travel. Between 2001 and 2011, 40% of measles cases came from outside the United States. In 2025, that dropped to 10% of cases imported, and even further to 6% of cases in 2026.
- Decreased measles vaccination rates. The measles, mumps, and rubella (MMR) vaccination rate among kindergarten students in the United States was 92.5% in the 2024-25 school year, down from the pre-pandemic rate of 95%.
* Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Jersey, New Mexico, New York City, New York State, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Wisconsin, and Wyoming.
Communicating about the Ongoing Measles Outbreak
Table of Contents
Topline Messages
- Measles is a highly contagious disease with serious possible complications, including hospitalization, long-term illness, and death. Someone who is infected can spread the disease to other people before developing or noticing any symptoms.
- Over 20% of children (from newborns to 19 years old) with confirmed measles cases in 2025 and 2026 were hospitalized. Children who contract measles are at risk of pneumonia and death. Adults are also at risk for hospitalization, especially people with immunocompromised health.
- Data show that unvaccinated people have a 90% likelihood of contracting measles if exposed. Unvaccinated children who have not previously been infected are more likely to get infected.
- One in five children who contract measles will be hospitalized.
- One in 20 children who contract measles will develop pneumonia.
- One to three children who contract measles in 1,000 will die.
- The measles-mumps-rubella (MMR) and measles-mumps-rubella-varicella (MMRV) vaccines are highly effective. Individuals with a history of prior infection or vaccination who have received the full series of MMR vaccines are 97% protected within two to three weeks of vaccination and are unlikely to contract measles.
- Measles infection can cause “immune amnesia” or immune suppression, effectively erasing the immune system’s memory and ability to protect against other diseases. This immune weakening can last anywhere from weeks to years, and increases the risk of other infections, even if you have built immunity from a previous infection.
Supporting Messages
The following information can be used in communications responses related to measles transmission, exposure, vaccine guidance, and vaccine safety information. This is not an exhaustive list to address the ongoing outbreak, and health departments and other organizations should consult federal and state authorities when developing responsive communications for their priority audiences.
Background on Measles
- Measles is one of the most highly contagious airborne diseases and is among the leading global causes of death in children, despite the existence of a highly effective and safe vaccine.
- The American Academy of Pediatrics (AAP) recommends that children and adolescents ages 12 months and older get the MMR or MMRV vaccine series to help protect them from serious illness. The American Academy of Family Physicians (AAFP) recommends that people ages 19 and older get the MMR vaccine to protect against measles.
- Children under five years of age, adults over 20 years of age, pregnant people, and people with immunocompromised health are most at risk of measles complications.
- Measles infection can cause a rash, along with high fevers, diarrhea, coughing, runny nose, and eye and ear infections. Someone who is infected can spread the airborne disease to others before noticing any symptoms, especially during the 4 days before and after the rash develops.
- In severe cases, measles causes children’s brains to swell, leading to seizures, deafness, cognitive disability, and possibly death. Children with measles can also contract pneumonia, the top cause of pediatric death from measles and a serious respiratory illness.
- Measles even causes immune system weakening that can last weeks to years. A suppressed immune system increases the risk of infection due to secondary bacterial and other infections.
- The United States lost its measles elimination status in November 2026 after ongoing measles spread and outbreaks in 2025 and 2026. Measles outbreaks are most common in communities where larger groups of people are unvaccinated. This is a major public health concern given that about 1 in 5 unvaccinated people in the U.S. with measles require hospitalization.
- Since 1968, the measles vaccine has been the single most effective and safe approach to ensure people do not experience hospitalization, long-lasting health impacts, or death due to this viral disease.
Vaccine Guidance
- People can protect themselves and their loved ones from measles and vaccine-preventable diseases like mumps, rubella, and/or varicella (chickenpox) by getting the measles-mumps-rubella (MMR) or measles-mumps-rubella-varicella (MMRV) vaccine.
- Children over 12 months are eligible to get two doses of the MMR vaccine or MMRV, which protects against all known strains of measles. It only takes a few days for antibodies to develop in response to the MMR and MMRV vaccines. Those who have received the full series of MMR or MMRV vaccines are 97% protected within two to three weeks of vaccination and are unlikely to contract measles.
- The AAP schedule recommends giving families a choice between the MMR vaccine along with the separate varicella (chickenpox) vaccine or the MMRV vaccine for the first dose. For the second dose, getting the MMRV vaccine is recommended to reduce the overall number of shots.
- The first dose of the MMR vaccine and a separate VAR vaccine are typically administered between ages 12 and 15 months. The same applies to the MMRV vaccine if that option is chosen.
- The second dose of the MMR vaccine and a separate VAR vaccine are typically administered at 4 years old. The same applies to the MMRV vaccine option.
- Due to their long-lasting nature, the MMR and MMRV vaccine doses are typically provided years apart; however, children in high-risk settings can get their second dose as soon as 28 days after the first dose.
- AAP does not recommend one of these options over the other for toddlers. AAP does recommend that parents or guardians be counseled about the rare possibility of their child developing a febrile seizure one to two weeks after immunization with MMRV for the first dose. It’s important to keep in mind that febrile seizures can occur for a variety of reasons in young children and are considered to have no long-term consequences.
- Children who are traveling with family to overseas areas where measles is less controlled may require slightly different vaccine timing to provide the best protection while abroad. In most cases, children should complete the doses at least two weeks before traveling.
- Adults ages 19 and over can get the MMR vaccine if they have not been vaccinated or do not have evidence of immunity.
- Most adults with evidence of measles immunity do not routinely need another MMR dose. Evidence of immunity includes documented MMR vaccination, laboratory evidence of immunity, documented measles infection, or being born before 1957. One documented MMR dose is generally sufficient for most adults. A second dose may be recommended for people at higher risk, including healthcare workers, college students, international travelers, and people in areas experiencing measles outbreaks.
- People who cannot find their vaccination records or are unsure whether they had measles should talk with their healthcare professional about vaccination or immunity testing. An additional MMR dose is generally safe when recommended by a health care professional. MMR should not be given during pregnancy.
- People who are pregnant, trying to get pregnant, or believe they could be pregnant should contact their healthcare professional immediately to test for measles and discuss options. Pregnant people cannot get the MMR vaccine until they are no longer pregnant.
For additional and more personalized information about vaccine options, encourage your audiences to contact their healthcare professional.
Exposure Guidance
- Along with getting vaccinated, the most helpful actions someone can take to prevent the spread of measles include isolating if they have a rash or believe they have been exposed, wearing a mask if around others, and contacting a healthcare provider immediately. Isolation is a key health precaution used to prevent people with confirmed or suspected measles from spreading the virus through respiratory droplets or cross-contaminated surfaces.
- If you become sick and have not been vaccinated against measles:
- Contact a healthcare professional immediately and alert them that you believe you were exposed to measles.
- Ask them about receiving an MMR or MMRV vaccine and discuss treatment options.
- Children who are unvaccinated, who have not completed both doses of the MMR or MMRV vaccine, or are unsure of their vaccination status should receive an MMR vaccine immediately if they are exposed to measles. Unvaccinated people who have been exposed to measles can still receive the MMR vaccine up to 72 hours after exposure to help prevent or reduce the severity of an infection
- You should isolate for 21 days after your exposure.
- You should wear a mask and disinfect surfaces when near others to avoid the spread of germs in the air and on common household items.
- Contact a healthcare professional immediately and alert them that you believe you were exposed to measles.
- If you become sick and have been vaccinated against measles:
- Contact a healthcare professional immediately and alert them that you believe you were exposed to measles.
- Discuss your vaccine history with them as part of determining possible treatment options.
- You should quarantine to limit contact with others. You may be advised to stay home for four days if you develop the measles rash.
- You should wear a mask and disinfect surfaces when near others to avoid the spread of germs in the air and on common household items.
- Contact a healthcare professional immediately and alert them that you believe you were exposed to measles.
Communications Considerations
Here are some questions to consider when communicating about the measles outbreak and measles (MMR) vaccines.
Who is your audience?
The more specific you can get about your audience, the more effective you can be in providing useful, relevant information.
Consider:
- Do I know what type of insurance my audience has? Am I specifically targeting people with public, private, or no insurance?
- Am I communicating with individuals or organizations? If an organization, what kind of organization—school, employer, business, health care facility, etc.?
What do you want your audience to do with this information?
Examples:
- I want my community to follow specific guidance.
- I want constituents to reach out to their insurer if they have questions about specific vaccine coverage.
- I want community members to share this message with friends or family.
- I want trusted messengers to help amplify this information.
What is your local context?
Consider:
- Local or state policies regarding active outbreaks that will directly impact your community.
- Your county’s measles case rate.
Read our Plain Language for Public Health Guide for more tips for effective, relevant, and accessible communications.



